$16.80
1.22[7.83%]
At close: Apr 24
$16.80
0[0.00%]
After Hours: 7:01AM EDT
Calumet Specialty Prods
(NASDAQ:CLMT)Calumet Specialty Prods Stock (NASDAQ:CLMT), Analyst Ratings, Price Targets, Predictions
Calumet Specialty Products Partners LP has a consensus price target of $23.07, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Goldman Sachs, and Goldman Sachs on April 22, 2024, March 21, 2024, and December 14, 2023. With an average price target of $20.33 between HC Wainwright & Co., Goldman Sachs, and Goldman Sachs, there's an implied 21.03% upside for Calumet Specialty Products Partners LP from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Goldman Sachs
UBS
Wells Fargo
TD Cowen
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Calumet Specialty Prods
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 48.81% | HC Wainwright & Co. | Amit Dayal | → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2024 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 1.19% | Goldman Sachs | Neil Mehta | $19 → $17 | Maintains | Buy | Get Alert |
| 12/14/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 13.1% | Goldman Sachs | Neil Mehta | $17 → $19 | Maintains | Buy | Get Alert |
| 10/31/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 1.19% | Goldman Sachs | Neil Mehta | $19 → $17 | Maintains | Buy | Get Alert |
| 08/07/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 48.81% | HC Wainwright & Co. | Amit Dayal | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 13.1% | Goldman Sachs | Neil Mehta | $20 → $19 | Maintains | Buy | Get Alert |
| 05/15/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 16.07% | UBS | Manav Gupta | $18.5 → $19.5 | Maintains | Neutral | Get Alert |
| 05/08/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 60.71% | Wells Fargo | Roger Read | $29 → $27 | Maintains | Overweight | Get Alert |
| 05/08/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 36.9% | TD Cowen | Jason Gabelman | $21 → $23 | Maintains | Outperform | Get Alert |
| 01/25/2023 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 48.81% | HC Wainwright & Co. | Amit Dayal | $28 → $25 | Maintains | Buy | Get Alert |
| 12/14/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | -6.55% | UBS | Manav Gupta | → $15.7 | Initiates | → Neutral | Get Alert |
| 08/18/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 36.9% | Goldman Sachs | Neil Mehta | $14 → $23 | Upgrade | Neutral → Buy | Get Alert |
| 06/28/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 19.05% | Cowen & Co. | Jason Gabelman | $18 → $20 | Maintains | Outperform | Get Alert |
| 05/09/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 19.05% | Cowen & Co. | Jason Gabelman | $18 → $20 | Maintains | Outperform | Get Alert |
| 04/21/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 72.62% | Wells Fargo | Roger Read | $27 → $29 | Maintains | Overweight | Get Alert |
| 02/28/2022 | CLMT | Buy Now | Calumet Specialty Prods | $16.80 | 66.67% | HC Wainwright & Co. | Amit Dayal | $19 → $28 | Maintains | Buy | Get Alert |
| 11/23/2021 | CLMT | Buy Now | Calumet Specialty | $16.80 | 78.57% | Wolfe Research | Sam Margolin | — | Upgrade | Peer Perform → Outperform | Get Alert |
| 11/23/2021 | CLMT | Buy Now | Calumet Specialty | $16.80 | 36.9% | Cowen & Co. | Jason Gabelman | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/15/2021 | CLMT | Buy Now | Calumet Specialty | $16.80 | -34.52% | Goldman Sachs | Neil Mehta | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Calumet Specialty Prods (CLMT)?
The latest price target for Calumet Specialty Prods (NASDAQ: CLMT) was reported by HC Wainwright & Co. on April 22, 2024. The analyst firm set a price target for $25.00 expecting CLMT to rise to within 12 months (a possible 48.81% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Calumet Specialty Prods (CLMT)?
The latest analyst rating for Calumet Specialty Prods (NASDAQ: CLMT) was provided by HC Wainwright & Co., and Calumet Specialty Prods reiterated their buy rating.
When was the last upgrade for Calumet Specialty Prods (CLMT)?
The last upgrade for Calumet Specialty Products Partners LP happened on August 18, 2022 when Goldman Sachs raised their price target to $23. Goldman Sachs previously had a neutral for Calumet Specialty Products Partners LP.
When was the last downgrade for Calumet Specialty Prods (CLMT)?
There is no last downgrade for Calumet Specialty Prods.
When is the next analyst rating going to be posted or updated for Calumet Specialty Prods (CLMT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet Specialty Prods, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet Specialty Prods was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Calumet Specialty Prods (CLMT) correct?
While ratings are subjective and will change, the latest Calumet Specialty Prods (CLMT) rating was a reiterated with a price target of $0.00 to $25.00. The current price Calumet Specialty Prods (CLMT) is trading at is $16.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.